Jiangsu XinChen-Techfields Pharma Co., LTD.
Quick facts
Phase 3 pipeline
- Celecoxib capsules · Rheumatology / Pain Management
Celecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing the production of prostaglandins that mediate inflammation and pain.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: